Axsome Therapeutics, Inc.
(NASDAQ : AXSM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc 11.04%5.331.6%$118.35m
VRXValeant Pharmaceuticals International, Inc. 2.05%14.9214.1%$87.79m
PRGOPerrigo Co. Plc 0.02%47.586.8%$86.57m
JAZZJazz Pharmaceuticals Plc 0.52%106.322.3%$84.31m
CTLTCatalent, Inc. 1.35%53.102.2%$75.85m
ICLRICON plc -0.08%144.954.2%$73.19m
UTHRUnited Therapeutics Corp. 0.77%96.5014.3%$72.25m
HZNPHorizon Therapeutics Plc -3.63%30.806.5%$70.11m
AXSMAxsome Therapeutics, Inc. -5.70%50.501.9%$61.48m
GWPHGW Pharmaceuticals Plc 6.09%91.856.2%$58.74m
ICPTIntercept Pharmaceuticals, Inc. 3.04%64.7616.8%$43.34m
SAGESAGE Therapeutics, Inc. 2.12%28.978.6%$40.70m
PBHPrestige Consumer Healthcare, Inc. -0.89%38.824.0%$35.35m
PCRXPacira Biosciences, Inc. 7.13%34.2810.4%$32.35m
MYOKMyoKardia, Inc. 0.17%48.132.1%$26.80m

Company Profile

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-09, AXS-12, and AXS-14 which are developing for multiple pain and primary care indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.